Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11

BACKGROUND: C. albicans is a pathogenic yeast that is the most common cause of fungal infections in humans. Unfortunately, the yeast’s resistance to the antifungal medication fluconazole (FLC) is increasing; furthermore, testing its susceptibility to FLC by conventional methods takes time, resulting...

Descripción completa

Detalles Bibliográficos
Autores principales: Maenchantrarath, Chanika, Khumdee, Pradchama, Samosornsuk, Seksun, Mungkornkaew, Narissara, Samosornsuk, Worada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188158/
https://www.ncbi.nlm.nih.gov/pubmed/35689195
http://dx.doi.org/10.1186/s12866-022-02564-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188158/
https://www.ncbi.nlm.nih.gov/pubmed/35689195
http://dx.doi.org/10.1186/s12866-022-02564-4

Ejemplares similares